Systemic macrophage migration inhibitory factor release following hepatic resection

被引:12
作者
Gando, S
Nishihira, J
Kobayashi, S
Morimoto, Y
Matsushita, M
Kemmotsu, O
机构
[1] Hokkaido Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Sapporo, Hokkaido 060, Japan
[2] Hokkaido Univ, Sch Med, Cent Res Inst, Sapporo, Hokkaido 060, Japan
[3] Hokkaido Univ, Sch Med, Dept Surg, Sapporo, Hokkaido 060, Japan
关键词
macrophage migration inhibitory factor; hepatic resection; tumor necrosis factor alpha; cortisol; surgical stress; outcome;
D O I
10.1007/s005950170094
中图分类号
R61 [外科手术学];
学科分类号
摘要
We set out to determine the responses of macrophage migration inhibitory factor (MIF) to hepatic resection and investigate its role in predicting short-term postoperative morbidity and outcome. Blood samples from 29 patients undergoing hepatic resection and eight healthy volunteers were obtained serially for 24h and assayed for serum MIF, cortisol, and tumor necrosis factor (TNF)-alpha. The MIF and cortisol levels showed a parallel increase and their peak levels were significantly correlated (r(2) = 0.33, P = 0.0011). The TNF-alpha levels also increased during and after hepatic resection, but did not correlate with the MIF levels. The patients were classified into an extended hepatectomy group (n = 9); a lobectomy/segmentectomy group (n = 12); and a subsegmentectomy group (n = 8). There were no differences in the time courses of MIF (P = 0.8699), cortisol (P = 0.7485), and TNF-alpha (P = 0.3819) among the three groups. No patients developed organ dysfunction and all were discharged from the intensive care unit without any complications. Our findings demonstrate that MIF production occurs in patients undergoing hepatic resection. Surgical stress may play a more important role in MIF secretion than inflammatory stimulus by TNF-alpha in these patients. Therefore, MIF minimally affects short-term postoperative morbidity and outcome.
引用
收藏
页码:605 / 609
页数:5
相关论文
共 18 条
[1]
Bacher M, 1997, AM J PATHOL, V150, P235
[2]
Badia JM, 1998, EUR J SURG, V164, P185
[3]
MECHANISM OF A REACTION IN VITRO ASSOCIATED WITH DELAYED-TYPE HYPERSENSITIVITY [J].
BLOOM, BR ;
BENNETT, B .
SCIENCE, 1966, 153 (3731) :80-&
[4]
MIF rediscovered: Cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response [J].
Bucala, R .
FASEB JOURNAL, 1996, 10 (14) :1607-1613
[5]
MACROPHAGE IS AN IMPORTANT AND PREVIOUSLY UNRECOGNIZED SOURCE OF MACROPHAGE-MIGRATION INHIBITORY FACTOR [J].
CALANDRA, T ;
BERNHAGEN, J ;
MITCHELL, RA ;
BUCALA, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (06) :1895-1902
[6]
Macrophage migration inhibitory factor (MIF): A glucocorticoid counter-regulator within the immune system [J].
Calandra, T ;
Bucala, R .
CRITICAL REVIEWS IN IMMUNOLOGY, 1997, 17 (01) :77-88
[7]
MIF AS A GLUCOCORTICOID-INDUCED MODULATOR OF CYTOKINE PRODUCTION [J].
CALANDRA, T ;
BERNHAGEN, J ;
METZ, CN ;
SPIEGEL, LA ;
BACHER, M ;
DONNELLY, T ;
CERAMI, A ;
BUCALA, R .
NATURE, 1995, 377 (6544) :68-71
[9]
DONELLY SC, 1997, NAT MED, V3, P320
[10]
Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease [J].
Donnelly, SC ;
Bucala, R .
MOLECULAR MEDICINE TODAY, 1997, 3 (11) :502-507